Singapore Health Sciences Authority - National regulatory authority for health products in Singapore
显示 2021 年的审批记录
仅限当前页。暂不支持搜索完整审批数据集。
药物名称 | 公司 | 适应症 | 日期 | 类型 |
|---|---|---|---|---|
| NUCALA SOLUTION FOR INJECTION IN PRE-FILLED PEN 100MG/ML | GLAXOSMITHKLINE PTE LTD | NUCALA SOLUTION FOR INJECTION IN PRE-FILLED PEN 100MG/ML | Apr 27, 2021 | SIN16172P |
| INTORICOXIB FILM COATED TABLET 90MG | INTEGA PTE. LTD. | INTORICOXIB FILM COATED TABLET 90MG | Apr 23, 2021 | SIN16167P |
| INTORICOXIB FILM COATED TABLET 60MG | INTEGA PTE. LTD. | INTORICOXIB FILM COATED TABLET 60MG | Apr 23, 2021 | SIN16168P |
| INTORICOXIB FILM COATED TABLET 120MG | INTEGA PTE. LTD. | INTORICOXIB FILM COATED TABLET 120MG | Apr 23, 2021 | SIN16166P |
| FEMCORD SOLUTION FOR INJECTION 250 MG/5 ML | ACCORD HEALTHCARE PRIVATE LIMITED | FEMCORD SOLUTION FOR INJECTION 250 MG/5 ML | Apr 21, 2021 | SIN16163P |
| TACROCIN 5- TACROLIMUS CAPSULE USP 5 MG | ACCORD HEALTHCARE PRIVATE LIMITED | TACROCIN 5- TACROLIMUS CAPSULE USP 5 MG | Apr 21, 2021 | SIN16157P |
| TACROLIMUS–TEVA PROLONGED RELEASE HARD CAPSULE 1MG | TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD. | TACROLIMUS–TEVA PROLONGED RELEASE HARD CAPSULE 1MG | Apr 21, 2021 | SIN16161P |
| TACROLIMUS–TEVA PROLONGED RELEASE HARD CAPSULE 0.5MG | TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD. | TACROLIMUS–TEVA PROLONGED RELEASE HARD CAPSULE 0.5MG | Apr 21, 2021 | SIN16162P |
| TALIS 20 - TADALAFIL TABLETS USP 20MG | RANBAXY (MALAYSIA) SDN. BHD. | TALIS 20 - TADALAFIL TABLETS USP 20MG | Apr 21, 2021 | SIN16156P |
| TACROLIMUS–TEVA PROLONGED RELEASE HARD CAPSULE 5MG | TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD. | TACROLIMUS–TEVA PROLONGED RELEASE HARD CAPSULE 5MG | Apr 21, 2021 | SIN16160P |
| TACROCIN 1- TACROLIMUS CAPSULE USP 1 MG | ACCORD HEALTHCARE PRIVATE LIMITED | TACROCIN 1- TACROLIMUS CAPSULE USP 1 MG | Apr 21, 2021 | SIN16158P |
| OZEMPIC 0.25MG, 0.5MG/DOSE SOLUTION FOR INJECTION IN PRE-FILLED PEN 1.34MG/ML | NOVO NORDISK PHARMA (SINGAPORE) PTE LTD | OZEMPIC 0.25MG, 0.5MG/DOSE SOLUTION FOR INJECTION IN PRE-FILLED PEN 1.34MG/ML | Apr 21, 2021 | SIN16165P |
| TACROCIN 0.5- TACROLIMUS CAPSULE USP 0.5 MG | ACCORD HEALTHCARE PRIVATE LIMITED | TACROCIN 0.5- TACROLIMUS CAPSULE USP 0.5 MG | Apr 21, 2021 | SIN16159P |
| OZEMPIC 1MG/DOSE SOLUTION FOR INJECTION IN PRE-FILLED PEN 1.34MG/ML | NOVO NORDISK PHARMA (SINGAPORE) PTE LTD | OZEMPIC 1MG/DOSE SOLUTION FOR INJECTION IN PRE-FILLED PEN 1.34MG/ML | Apr 21, 2021 | SIN16164P |
| ENERZAIR BREEZHALER INHALATION POWDER, HARD CAPSULE 150 MCG /50 MCG /160 MCG | NOVARTIS (SINGAPORE) PTE LTD | ENERZAIR BREEZHALER INHALATION POWDER, HARD CAPSULE 150 MCG /50 MCG /160 MCG | Apr 14, 2021 | SIN16153P |
| FULVESTRANT-TEVA SOLUTION FOR INJECTION 250MG/5ML | TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD. | FULVESTRANT-TEVA SOLUTION FOR INJECTION 250MG/5ML | Apr 14, 2021 | SIN16154P |
| EP-FENO TABLET 145MG | EURO ASIA MEDICO PTE. LTD. | EP-FENO TABLET 145MG | Apr 14, 2021 | SIN16155P |
| FULVESTRANT SANDOZ SOLUTION FOR INJECTION IN PREFILLED-SYRINGE 250MG/5ML | SANDOZ SINGAPORE PTE. LTD. | FULVESTRANT SANDOZ SOLUTION FOR INJECTION IN PREFILLED-SYRINGE 250MG/5ML | Apr 13, 2021 | SIN16152P |
| MVASI CONCENTRATE FOR SOLUTION FOR INFUSION 25 MG/ML | AMGEN BIOTECHNOLOGY SINGAPORE PTE. LTD. | MVASI CONCENTRATE FOR SOLUTION FOR INFUSION 25 MG/ML | Apr 10, 2021 | SIN16151P |
| EYBELIS OPHTHALMIC SOLUTION 0.002% | SANTEN PHARMACEUTICAL ASIA PTE. LTD. | EYBELIS OPHTHALMIC SOLUTION 0.002% | Apr 7, 2021 | SIN16150P |
